These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28394426)

  • 1. Advanced platelet parameters: underutilized tools in the diagnosis and management of thrombopoietic states?
    George MR; Creer MH
    Transfusion; 2017 Apr; 57(4):874-875. PubMed ID: 28394426
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombopoietin and reticulated platelets as thrombopoietic markers in colorectal cancer.
    Dymicka-Piekarska V; Kemona H
    Thromb Res; 2008; 122(1):141-3. PubMed ID: 18061247
    [No Abstract]   [Full Text] [Related]  

  • 3. Normal and pathological dynamics of platelets in humans.
    Langlois GP; Craig M; Humphries AR; Mackey MC; Mahaffy JM; Bélair J; Moulin T; Sinclair SR; Wang L
    J Math Biol; 2017 Dec; 75(6-7):1411-1462. PubMed ID: 28391511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of platelet number and regulation of thrombopoiesis.
    Kaushansky K
    Hematology Am Soc Hematol Educ Program; 2009; ():147-52. PubMed ID: 20008193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietic status of patients on haemodialysis.
    Bat T; Bat BE; El-Moghraby A; Patel S; Feng X; Dunbar CE; Sarac E
    Br J Haematol; 2016 Mar; 172(6):954-7. PubMed ID: 26887628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of thrombopoietic activity in plasma by stimulation of suppressed thrombopoiesis.
    Shreiner DP; Levin J
    J Clin Invest; 1970 Sep; 49(9):1709-13. PubMed ID: 5449707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation.
    Hong KH; Kim HK; Kim JE; Jung JS; Han KS; Cho HI
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):409-14. PubMed ID: 19528793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
    Levy B; Arnason JE; Bussel JB
    Curr Opin Oncol; 2008 Nov; 20(6):690-6. PubMed ID: 18841052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietic activity in newborn infants.
    Bessler H; Sirota L; Weissman Z; Dulitzky F; Djaldetti M
    Biol Neonate; 1986; 49(2):61-5. PubMed ID: 3697428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of thrombopoietic activity through the quantification of megakaryocytes in bone marrow cytology and reticulated platelets.
    Silva LF; Golim MA; Takahira RK
    Res Vet Sci; 2012 Aug; 93(1):313-7. PubMed ID: 21820687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
    Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
    Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the potential for thrombopoietic agents in acute leukemia?
    Kuter DJ
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into thrombopoiesis in neonatal sepsis.
    Eissa DS; El-Farrash RA
    Platelets; 2013; 24(2):122-8. PubMed ID: 22746320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
    Krzyzanski W; Perez-Ruixo JJ; Harrold J
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):709-20. PubMed ID: 26341875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
    Zang W; Wei X; Wang S; Wang D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):128-31. PubMed ID: 11877062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietic agents.
    Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
    Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.